Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 104Carcinoma, Non-Small-Cell Lung 21Skin Neoplasms 19Colorectal Neoplasms 15Carcinoma, Renal Cell 14Sarcoma 13Squamous Cell Carcinoma of Head and Neck 12Lung Neoplasms 12Carcinoma, Merkel Cell 12Breast Neoplasms 12Ovarian Neoplasms 11Carcinoma, Basal Cell 11Urinary Bladder Neoplasms 10Pancreatic Neoplasms 10Neoplasms 10Stomach Neoplasms 9Neoplasm Metastasis 9Head and Neck Neoplasms 9Carcinoma, Hepatocellular 9Thyroid Neoplasms 8Prostatic Neoplasms 8Lymphoma, T-Cell, Cutaneous 8Mycosis Fungoides 7Brain Neoplasms 7Uterine Cervical Neoplasms 6Recurrence 6Lymphoma, Large-Cell, Anaplastic 6Lymphoma 6Esophageal Neoplasms 6Carcinoma, Transitional Cell 6

Interventions

Standard of Care 1Practice Guidelines as Topic 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Spondylitis, Ankylosing × Dermatologic × 30 days × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡